StemCell Therapy

North America has been the largest market for protein expression, with the U.S. as the larger contributor to the regional market as compared to Canada.

The protein expression market valued at $1.4 billion in 2016, and during the forecast period, it is expected to grow at an 11.7% CAGR, generating revenue of $3.0 billion by 2023. The key drivers of the market are technological advancements, growing life sciences sector, and increasing chronic disease prevalence, funding for protein-based research, and geriatric population.

Protein expression is a collective term for ways in which proteins are synthesized, modified, and regulated in living organisms.

Download sample copy of this report at@bit.ly/38YmQAq

A prominent trend in the protein expression marketis the increasing research and development (R&D) activities on recombinant proteins. The technologies that are used to produce recombinant proteins, such as gene cloning and genetic engineering, have revolutionized the life sciences sector and enabled the production of biopharmaceuticals at an industrial scale.

Their production on such a large scale has led to their application in disease diagnosis and treatment. Many pharmaceutical companies are focusing on the production of recombinant proteins and their expression systems to support the drug discovery process and develop biotherapeutics.

The protein expression market is segmented by region, system, end user, product and services, and application.

Based on system, the categories are algal-based, prokaryotic, cell-free, mammalian cell, yeast, and insect cell expression systems. In 2016, prokaryotic expression systems registered the largest share as they are comparatively cheaper than other expression systems, such as insect cell and mammalian systems.

In addition, the shorter protein synthesis time of the prokaryotic expression system, as the bacteria multiply and grow rapidly in these systems, giving a higher yield, promotes their adoption.

Pre-AccessInquiry at@bit.ly/2SVOV5E

North America, Middle East & Africa, Europe, Latin America, and Asia-Pacific (APAC) are the subdivisions of the region segment of the protein expression market. In 2016, the market was dominated by North America, followed by Europe.

Even though during the forecast period, the market is expected to be led by North America, the fastest growing market would be APAC. This may be attributed to the increasing geriatric population, rising R&D funds, improving per capita income, and rising prevalence of chronic diseases in the region.

Therefore, the market for protein expression is set to experience remarkable growth during the forecast period owing to an increase in drug discovery and development and growing prevalence of several types of diseases.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Read more here:
Protein Expression Market size, leaders, segment analysis and future scope scrutinized in the new analysis - WhaTech Technology and Markets News

This entry was posted on February 25, 2020 at 5:42 pm and is filed under Genetic Engineering. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |